abstract |
A sustained release oral composition of an antipsychotic agent comprising antipsychotic agent, λ-carrageenan and one or more pharmaceutically acceptable excipients; wherein the antipsychotic agent is 2-[2-(4-dibenzo {b,f}[1,4-thiazepin-11yl -1-piperazinyl)ethoxy ethanol] or its pharmaceutically acceptable salt. |